Search for Clinical Trial Results
Nasopharyngeal Carcinoma - 31 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2006-09-20 Interventions:
|
Active, not recruiting |
Study Name: Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2010-11-22 Interventions:
|
Terminated |
Study Name: A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients Condition: Nasopharyngeal Carcinoma Date: 2005-09-13 Interventions: Drug: Cisplatin,5-FU,Leucovorin |
Active, not recruiting |
Study Name: Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. Condition: Nasopharyngeal Carcinoma Date: 2005-09-09 |
Active, not recruiting |
Study Name: Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2008-05-09 Interventions:
|
NOT_YET_RECRUITING |
Study Name: Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer Condition: Date: 2024-05-19 Interventions: Undergo collection of blood samples |
NOT_YET_RECRUITING |
Study Name: Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma Condition: Date: 2024-05-19 Interventions: 10mg/kg administered intravenously (IV) |
RECRUITING |
Study Name: Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis Condition: Date: 2024-05-19 Interventions: Patients in the intervention arm will receive a decolonization regimen, consisting of intranasal mupirocin ointment to be applied twice daily to the n |
NOT_YET_RECRUITING |
Study Name: Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy Condition: Date: 2024-05-19 Interventions: Enteral immunonutrition (Oral Impact�, Nestle), 250ml/ bottle, 2 bottles per day, from 5 days before radiotherapy to the end of radiotherapy. |
RECRUITING |
Study Name: Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2024-05-19 Interventions: nimotuzumab 200mg/week in concurrent with IMRT, d1,d8,d15,d22,d29,d36 of RT |